These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7928215)

  • 1. The question of dose for gadolinium chelates in magnetic resonance imaging.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats.
    Masui T; Takehara Y; Aoshima R; Kaneko M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 4. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
    Witte RJ; Anzai LL
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose contrast-enhanced MRI in multiple sclerosis.
    Koudriavtseva T; Pozzilli C; Di Biasi C; Iannilli M; Trasimeni G; Gasperini C; Argentino C; Gualdi GF
    Neuroradiology; 1996 May; 38 Suppl 1():S5-9. PubMed ID: 8811671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
    Puttagunta NR; Gibby WA; Smith GT
    Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of relative cerebral blood volume changes with visual stimulation by 'double-dose' gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging.
    Frank JA; Mattay VS; Duyn J; Sobering G; Barrios FA; Zigun J; Sexton R; Kwok P; Woo J; Moonen C
    Invest Radiol; 1994 Jun; 29 Suppl 2():S157-60. PubMed ID: 7928216
    [No Abstract]   [Full Text] [Related]  

  • 9. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and medico-legal implications of intra-articular gadolinium use.
    Balkissoon AR
    Semin Ultrasound CT MR; 1997 Aug; 18(4):276-7. PubMed ID: 9285995
    [No Abstract]   [Full Text] [Related]  

  • 11. Sonographic guidance of needle position for MR arthrography of the shoulder.
    Valls R; Melloni P
    AJR Am J Roentgenol; 1997 Sep; 169(3):845-7. PubMed ID: 9275909
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 13. Total cerebrospinal fluid enhancement following intravenous Gd-DTPA administration in a case of meningiomatosis.
    Berger B; Ortiz O; Gold A; Hilal SK
    AJNR Am J Neuroradiol; 1992; 13(1):15-8. PubMed ID: 1595433
    [No Abstract]   [Full Text] [Related]  

  • 14. [The magnetic resonance tomography of osteochondrosis dissecans of the knee joint after intravenous gadolinium-DTPA administration].
    Adam G; Neuerburg J; Peiss J; Bohndorf K; Günther RW
    Rofo; 1994 May; 160(5):459-64. PubMed ID: 8173056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
    J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-dose Gd-DTPA: detectability of intraparenchymal brain metastasis].
    Tatsuno S; Hata Y; Tada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct; 56(12):855-9. PubMed ID: 8940816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosage of gadoteridol and adverse reactions relative to gadopentetate.
    Hieronim DE; Kanal E; Swanson DP
    Am J Health Syst Pharm; 1995 Nov; 52(22):2556-9. PubMed ID: 8590239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.